Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway.
Angiotensin-Converting Enzyme 2
/ metabolism
Animals
Anti-Inflammatory Agents
/ toxicity
Dexamethasone
/ toxicity
Female
Hep G2 Cells
Humans
Male
MicroRNAs
/ metabolism
Non-alcoholic Fatty Liver Disease
/ chemically induced
Pregnancy
Prenatal Exposure Delayed Effects
/ chemically induced
Proto-Oncogene Mas
Proto-Oncogene Proteins
/ metabolism
Rats
Rats, Wistar
Receptors, G-Protein-Coupled
/ metabolism
YY1 Transcription Factor
/ metabolism
Angiotensin-converting enzyme 2-Mas receptor signaling pathway
Nonalcoholic fatty liver disease
Prenatal dexamethasone exposure
Yin Yang-1
miR-122
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
28
10
2020
revised:
30
12
2020
accepted:
11
01
2021
pubmed:
19
1
2021
medline:
2
7
2021
entrez:
18
1
2021
Statut:
ppublish
Résumé
Epidemiological studies have shown that nonalcoholic fatty liver disease (NAFLD) has an intrauterine developmental origin. We aimed to demonstrate that NAFLD is caused by prenatal dexamethasone exposure (PDE) in adult male rat offspring and to investigate the intrauterine programming mechanism. Liver samples were obtained on gestational day (GD) 21 and postnatal week (PW) 28. The effects and epigenetic mechanism of dexamethasone were studied with bone marrow mesenchymal stem cells (BMSCs) hepatoid differentiated cells and other cell models. In the PDE group, lipid accumulation increased, triglyceride synthesis-related gene expression increased, and oxidation-related gene expression decreased in livers of adult male rat offspring. In utero, hepatic triglyceride synthesis increased and oxidative function decreased in PDE fetal male rats. Moreover, low hepatic miR-122 expression, high Yin Yang-1 (YY1) expression and angiotensin-converting enzyme 2 (ACE2)-Mas receptor (MAS1) signaling pathway inhibition were observed before and after birth. At the cellular level, dexamethasone (100-2500 nM) elevated the intracellular triglyceride content, increased triglyceride synthesis-related gene expression and decreased oxidation-related gene expression. Dexamethasone treatment also decreased miR-122 expression, increased YY1 expression and inhibited the ACE2-MAS1 signaling pathway. Interference or overexpression of glucocorticoid receptor (GR), miR-122, YY1 and ACE2 could reverse the changes in downstream gene expression. In summary, PDE could induce NAFLD in adult male rat offspring. The programming mechanism included inhibition of miR-122 expression after GR activation, and dexamethasone increased hepatocyte YY1 expression; these effects resulted in ACE2-MAS1 signaling pathway inhibition, which led to increased hepatic triglyceride synthesis and decreased oxidative function. The increased triglyceride synthesis and decreased oxidative function of hepatocytes caused by low miR-122 expression due to dexamethasone could continue postnatally, eventually leading to NAFLD in adult rat offspring.
Identifiants
pubmed: 33460628
pii: S0006-2952(21)00016-2
doi: 10.1016/j.bcp.2021.114420
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
MAS1 protein, human
0
MIRN122 microRNA, rat
0
Mas1 protein, rat
0
MicroRNAs
0
Proto-Oncogene Mas
0
Proto-Oncogene Proteins
0
Receptors, G-Protein-Coupled
0
YY1 Transcription Factor
0
Yy1 protein, rat
0
Dexamethasone
7S5I7G3JQL
Ace2 protein, rat
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
114420Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.